ConcertAI Press Kit

Company Overview

ConcertAI is the leader in predictive and generative AI SaaS and real-world data research solutions for healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARAai™ technologies, and scientific expertise in partnership with over 46 leading biomedical innovators, 2,000 healthcare providers, and medical societies. TeraRecon® provides advanced radiological image visualizations and clinical AI decision augmentation solutions for MRI and CT. CancerLinQ® is an Initiative of ConcertAI, providing oncology providers with ASCO-aligned automated QOPI and ASCO Certified® quality solutions and SmartLinQ™ analytic services. Headquartered in Cambridge, MA, ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, and Tokyo. For more information, visit us at concertai.com.

Contact Details:

PR/Media Contact

Laura Corona, lcorona@treblepr.com

Marketing

Marketing@ConcertAI.com

Press Logo Images

Transparent Logos

BIO

ConcertAI CEO – Jeff Elton, PhD

Jeff Elton, Ph.D., is the founding CEO of ConcertAI, a leader in enterprise Generative and Predictive AI for life sciences and healthcare; SaaS Solutions for clinical development, advanced oncology insights, and clinical interpretation; and the largest multimodal, ‘AI ready,’ oncology data-as-a-service for life sciences and healthcare research. Prior to ConcertAI, Jeff was a Managing Director at Accenture Strategy/Patient Health; Senior Vice President of Strategy and Global Chief Operating Officer at Novartis Institutes for BioMedical Research, Inc.; and a partner at McKinsey & Company. He is the co-author of the widely cited book ‘Healthcare Disrupted’ (Wiley, 2016), numerous articles, widely read perspectives, and The ConcertAI Podcast. Jeff holds a Ph.D. and an M.B.A. from The University of Chicago.